Invitae: An Emerging Genetic Testing Company with Insider and Institutional Buying

Acorda Therapeutics: Attacking 'OFF' Symptoms in Parkinson's Disease

Fundamental Short Selling Research

Eric Fernandez, CFA

TwoRiversAnalytics

Equity Bottom-Up

<ul>
<li>This model seeks companies facing dangerously high leverage coupled with negative or declining cash flows.  It considers interest expense, capex and short term maturities for additional input. </li>
<li>The companies may not be viable given cash flows and capital structures.  These shorts tend to have  higher betas  and can have strong down moves as the crisis is recognized.</li>
<li>This week we flag: Invitae, AMC, 2U Inc., and Delek US</li>
</ul>


This model seeks companies facing dangerously high leverage coupled with negative or declining cash flows.  It considers interest expense, capex and short term maturities for additional input. 
The companies may not be viable given cash flows and capital structures.  These shorts tend to have  higher betas  and can have strong down moves as the crisis is recognized.
This week we flag: Invitae, AMC, 2U Inc., and Delek US


Solvency Risk Short Candidates: Invitae, AMC, 2U Inc., Delek US

Invitae Corp

Solvency Risk Short Candidates: Invitae, AMC, 2U Inc., Delek US